Study | Country Study period |
Population source | Exposure definition | Non-exposure definition | Sample size | Rmk |
---|---|---|---|---|---|---|
Hartz, 1975 |
USA 1958 - 1966 |
Pregnancies and their outcomes seen in one of the 12 university-affiliated hospitals. | Children exposed in utero to Chlordiazepoxide. |
unexposed (general population or NOS)
Children not exposed in utero to Chlordiazepoxide or Meprobamate. |
740 / 48412 | Overall mortality cannot be reported because the total number of exposed pregnancies considered for this outcome was not clearly provided; and Neurodevelopmental data cannot reported because only means were provided. |
Meng a (Controls unexposed, sibling), 2023 |
Taiwan 2004 - 2018 |
All singleton pregnancies of females aged 15–50 years who gave birth during the study period. | Sibling with at least one Chlordiazepoxide prescription received by the mother during early pregnancy (the first 20 weeks of pregnancy). |
sibling
Discordant matched sibling without benzodiazepine or Z-hypnotic prescriptions from 30 days before the date of the estimated last menstrual period to the end of the 20th week of pregnancy. |
-9 / -9 | Number of exposures not provided (authors provided number of Exposure discordant pairs and number of Case discordant pairs). |
Meng a (Controls unexposed, sick), 2023 |
Taiwan 2004 - 2018 |
All singleton pregnancies of females aged 15–50 years who gave birth during the study period. | At least one Chlordiazepoxide prescription received by a mother during early pregnancy (the first 20 weeks of pregnancy). |
unexposed, sick
Pregnant women with no benzodiazepine or Z-hypnotic prescriptions from 30 days before the date of the estimated last menstrual period to the end of the 20th week of pregnancy. |
943 / 2753670 | Use of results obtained with PS-FSW because more exposures, with a sick control group and sensitivity analyses (sibling control study, and paternal negative control design) that obtained similar results. |
Milkovich, 1974 |
USA 1959 - 1966 |
Liveborn infants of women with minor psychoneurotic compliants who reported for prenatal care at the East San Francisco Bay Area facilites of the Kaiser program. | Liveborn infants of women who received prescriptions of Chlordiazepoxide, for anxiety, during pregnancy. |
unexposed, sick
Liveborn infants of women with no prescription of Chlordiazepoxide, for anxiety, during the first 42 days of pregnancy (and very few were given between the 43rd and the 84th days). |
175 / 509 | |
Noh, 2022 |
South Korea 2011 - 2018 |
All pregnancies in women aged 20 to 45 years at delivery resulting in live births from 1 January 2011 to 31 December 2018, in South Korea. | Pregnant women who filled at least Chlordiazepoxide prescription during the first trimester (first 90 days of pregnancy). |
unexposed, sick
Pregnant women who were not prescribed any benzodiazepine from 3 months before the last menstrual period to the end of the first trimester (with similar psychiatric conditions after propensity score). |
381 / 3053381 | Propensity scored adjusted for indications and led to an unexposed cohort with similar psychiatric conditions => considered as unexposed, sick control groups. |
Study | Country Study period |
Case | Control | Sample size | Rmk |
---|---|---|---|---|---|
Bracken, 1981 |
USA 1974 - 1976 |
All newborns and stillborns with major congenital malformations, delivered at 5 major Connecticut hospitals and at 2 pediatric clinics or delivered elsewhere and referred to the 5 hospitals before 1 year of age. | Sampling of all apparently healthy live births in the 5 major Connecticut hospitals, randomly selected (subsequent ones from the delivery room log book). | 1370 / 2968 | This study assessed 2 different benzodiazepines. In order to avoid redundancy of controls, only 1 was reported in the meta-analysis of class, i.e the substance with the most exposed cases (i.e Diazepam). |
Czeizel, 2004 |
Hungary 1980 - 1996 |
Newborn infants with isolated congenital abnormality (CA) and multiple CA. Exclusions of some mild congenital abnormalities and minor congenital abnormality (methods in Czeizel 1999). | Two newborn infants without congenital anomalies matched to every case according to sex, birth week in the year when the case was born, and district of parents’ residence from the National Birth Registry of the Central Statistical Office. | 22865 / 38151 | Czeizel 2004, Czeizel 2003 and Eros 2002 used the same dataset to assess several benzodiazepines. To avoid redundancy of cases and controls, only the study with the most exposed cases was reported in the meta-analysis of class. |
Czeizel, 1987 |
Hungary 1970 - 1976 |
Infants born with facial clefting born during the study period. | Infants born witout facial clefting born during the study period. | 1201 / 1201 | Use of Retrospective case control study. This study assessed 3 different benzodiazepines. In order to avoid redundancy of controls, only 1 was reported in the meta-analysis of class, i.e the substance with the most exposed cases (i.e Diazepam). |
Kullander, 1976 |
Sweden 1963 - 1965 |
Infants with different kinds of malformations. | Infants without malformations. | 751 / 5002 | |
Rothman, 1979 |
USA 1973 - 1975 |
All infants with congenital heart disease born to Massachusetts women. | Births selected randomly from the roster of all Massachusetts births. | 390 / 1254 | The authors provided a 90% confidence interval, without adjustment => here a 95% confidence interval was calculated to be homogeneous with other studies. |
Sheehy, 2019 |
Canada 1998 - 2015 |
Pregnancies ending with spontaneous abortion (pregnancy loss between between the beginning of the sixth week of gestation and the 19th completed week of gestation, excluding planned or induced abortions). | Pregnancies ending with live births (5 for each case) randomly selected at the index date and matched with the case pregnancy by gestational age and calendar year. | 27149 / 134305 |